about
Experimental models of hepatotoxicity related to acute liver failureDevelopment of an invasively monitored porcine model of acetaminophen-induced acute liver failure.Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial liversAnimal models of acute hepatic failure.Barriers to the successful treatment of liver disease by hepatocyte transplantation.Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems.Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats.Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig modelA Macaca mulatta model of fulminant hepatic failure.Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury.Evaluation of liver support systems for preclinical testing by animal trials.An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.Antioxidant potential of a polyherbal antimalarial as an indicator of its therapeutic value.An experimental animal model of fulminant hepatic failure in pigs.Fulminant liver failure model with hepatic encephalopathy in the mouse.Ideal Experimental Rat Models for Liver DiseasesD-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?Effect of bone marrow mesenchymal stem cells transplantation on the serum and liver HMGB1 expression in rats with acute liver failureArtificial liver support in pigs with acetaminophen-induced acute liver failure.A new experimental model for acute hepatic failure in rats.Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure.Ex vivo magnetic resonance imaging of transplanted hepatocytes in a rat model of acute liver failure.Laparoscopy-assisted creation of a liver failure model in pigs.Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure.The effects of anesthetic regimen in 90% hepatectomy in rats.Neuromonitoring in a porcine model of acute hepatic failure.Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver.Mycophenolate mofetil and sirolimus in hepatocyte transplantation in an experimental model of toxic acute liver failure.Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.Effect of Conditioned Medium and Bone Marrow Stem Cell Lysate on the Course of Acetaminophen-Induced Liver Failure.Systemic treatment of acute liver failure with adipose derived stem cells.Upregulation of HO-1 with Haemin Alleviates LPS-Stimulated Pro-inflammatory Responses Through Downregulation of p38 Signalling Pathways in Rat Liver.
P2860
Q26775293-9B1BC6A9-C3F5-4F4A-9F00-22214050C828Q33547724-EBEE15CB-889A-40E0-9DBC-735B264E44FBQ33735279-C2A57153-875D-4992-B558-CB31B70367CAQ33890380-92725B26-CA53-4681-B9A5-02A32E75DBECQ34091618-DE5D23CC-6E45-49F4-99F3-75F10F38C185Q34153272-B1049FA3-CECF-4DED-9A2E-1209FE7C864FQ34696600-96E27E6D-7C84-4DFE-8180-0EF8426455E5Q35087066-B3C0DB01-6999-49C5-A2D8-C27D42B907C0Q35165901-7C0CF579-9C67-458A-A001-318C6B198A9CQ35594639-2800E584-64F1-4B09-BC37-C2E4F744C36AQ35725840-17F3BBD6-8B57-4303-9D3A-5D75160F00DAQ35942395-EE769ACB-EE4A-446E-A913-87EA29A79A6CQ36616615-0E35B9CF-04F5-47A5-9DEF-157C81E4EA04Q37250336-027797DC-6546-457A-B259-4E706E245B7CQ37433146-CC0F589D-209E-4C7A-AD60-678C424E4690Q37433894-F49456DB-845A-4D41-B1F2-9A25A9A78D7AQ38354469-BB060EF8-93B1-41C6-8525-4FB0F6FF5C05Q38595585-3DA3079F-BE1E-4584-BAA4-A8B5677A5365Q41531348-6365EB69-6ADD-4F7B-B5E5-AF611254A9CFQ41932789-9B7370E9-F27D-4258-A688-0ED97B9B85AEQ42261846-6A4D24F5-6854-4BA9-BC93-87D34F25DC36Q43055184-FB629351-A39E-415C-AEE8-D1075B13D2D4Q44311054-D2FC7167-2DD9-464D-92E6-0FE088C9BFA7Q44964482-F5D621F2-7BE8-4606-9FA0-C09645BFDF99Q46603807-C2B33782-528E-42FA-86C7-BED0E0B39C85Q47098992-D3BD9C4F-C14E-47EC-A60A-C8882FAFF5D5Q48126303-CA30F69F-5300-4672-9119-F942B1704C96Q48269960-E62D9C6A-208A-464D-9F7E-2D5387F8AD4FQ51092437-C7DA5342-488D-48C5-99F8-02760FC299A4Q53065142-E70C8CEE-2C19-44FE-8478-3A3105309EDEQ53257170-332709DD-BF3C-4B52-A50D-BC87F9C6F0CEQ53483570-900B593A-60E5-4083-B26E-8E98D7DEAA2AQ53659343-B571C667-FE41-4198-9857-DFD2ED9610D6Q54251869-9388D7F8-5B16-409A-B146-D37EA68BDDE9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Animal models of fulminant hepatic failure.
@en
Animal models of fulminant hepatic failure.
@nl
type
label
Animal models of fulminant hepatic failure.
@en
Animal models of fulminant hepatic failure.
@nl
prefLabel
Animal models of fulminant hepatic failure.
@en
Animal models of fulminant hepatic failure.
@nl
P356
P1476
Animal models of fulminant hepatic failure.
@en
P2093
Terblanche J
P2888
P304
P356
10.1007/BF01311235
P577
1991-06-01T00:00:00Z